Don M Bailey - Net Worth and Insider Trading

Don M Bailey Net Worth

The estimated net worth of Don M Bailey is at least $4 Million dollars as of 2024-12-26. Don M Bailey is the Director of Staar Surgical Co and owns about 145,139 shares of Staar Surgical Co (STAA) stock worth over $4 Million. Don M Bailey is the Director of Asterias Biotherapeutics Inc and owns about 88,235 shares of Asterias Biotherapeutics Inc (AST) stock worth over $83,382. Don M Bailey is also the Director of Lineage Cell Therapeutics Inc and owns about 158,801 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $80,195. Besides these, Don M Bailey also holds Mallinckrodt PLC (MNKKQ) , Comarco Inc (CMRO) . Details can be seen in Don M Bailey's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Don M Bailey has not made any transactions after 2024-02-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Don M Bailey

Don M Bailey Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Don M Bailey owns 7 companies in total, including Lineage Cell Therapeutics Inc (LCTX) , Asterias Biotherapeutics Inc (AST) , and OncoCyte Corp (OCX) among others .

Click here to see the complete history of Don M Bailey’s form 4 insider trades.

Insider Ownership Summary of Don M Bailey

Ticker	Comapny	Transaction Date	Type of Owner
LCTX	Lineage Cell Therapeutics Inc	2024-02-08	director
AST	Asterias Biotherapeutics Inc	2018-06-21	director
OCX	OncoCyte Corp	2016-08-29	director
		2015-05-13	director
		2011-08-05	director
		2007-06-11	director
		2014-08-14	director

Don M Bailey Latest Holdings Summary

Don M Bailey currently owns a total of 5 stocks. Among these stocks, Don M Bailey owns 145,139 shares of Staar Surgical Co (STAA) as of August 5, 2011, with a value of $4 Million and a weighting of 95.51%. Don M Bailey owns 88,235 shares of Asterias Biotherapeutics Inc (AST) as of May 13, 2016, with a value of $83,382 and a weighting of 2.24%. Don M Bailey also owns 158,801 shares of Lineage Cell Therapeutics Inc (LCTX) as of February 8, 2024, with a value of $80,195 and a weighting of 2.15%. The other 2 stocks Mallinckrodt PLC (MNKKQ) , Comarco Inc (CMRO) have a combined weighting of 0.11% among all his current holdings.

Latest Holdings of Don M Bailey

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
STAA	Staar Surgical Co	2011-08-05	145,139	24.55	3,563,162
AST	Asterias Biotherapeutics Inc	2016-05-13	88,235	0.95	83,382
LCTX	Lineage Cell Therapeutics Inc	2024-02-08	158,801	0.51	80,195
MNKKQ	Mallinckrodt PLC	2015-05-13	139,607	0.02	2,792
CMRO	Comarco Inc	2005-01-18	57,386	0.02	1,176

Holding Weightings of Don M Bailey

Don M Bailey Form 4 Trading Tracker

According to the SEC Form 4 filings, Don M Bailey has made a total of 0 transactions in Staar Surgical Co (STAA) over the past 5 years. The most-recent trade in Staar Surgical Co is the acquisition of 50,802 shares on August 5, 2011, which cost Don M Bailey around $280,935.

According to the SEC Form 4 filings, Don M Bailey has made a total of 0 transactions in Asterias Biotherapeutics Inc (AST) over the past 5 years. The most-recent trade in Asterias Biotherapeutics Inc is the acquisition of 88,235 shares on May 13, 2016, which cost Don M Bailey around $299,117.

According to the SEC Form 4 filings, Don M Bailey has made a total of 1 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Lineage Cell Therapeutics Inc is the acquisition of 96,155 shares on February 8, 2024, which cost Don M Bailey around $100,001.

More details on Don M Bailey's insider transactions can be found in the Insider Trading History of Don M Bailey table.

Insider Trading History of Don M Bailey

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Don M Bailey Trading Performance

GuruFocus tracks the stock performance after each of Don M Bailey's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Don M Bailey is 48.8%. GuruFocus also compares Don M Bailey's trading performance to market benchmark return within the same time period. The performance of stocks bought by Don M Bailey within 3 months outperforms 5 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Don M Bailey's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Don M Bailey

Average Return

Average return per transaction

Outperforming Transactions

2 out of 5 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	10.56
Relative Return to S&P 500(%)	14.6

Don M Bailey Ownership Network

Ownership Network List of Don M Bailey

No Data

Ownership Network Relation of Don M Bailey

Don M Bailey Owned Company Details

What does Lineage Cell Therapeutics Inc do?

Who are the key executives at Lineage Cell Therapeutics Inc?

Don M Bailey is the director of Lineage Cell Therapeutics Inc. Other key executives at Lineage Cell Therapeutics Inc include Chief Financial Officer Jill Ann Howe , General Counsel/Secretary Samuel George A. Iii , and director & President and CEO Brian M Culley .

Lineage Cell Therapeutics Inc (LCTX) Insider Trades Summary

Over the past 18 months, Don M Bailey made 1 insider transaction in Lineage Cell Therapeutics Inc (LCTX) with a net purchase of 96,155. Other recent insider transactions involving Lineage Cell Therapeutics Inc (LCTX) include a net purchase of 50,000 shares made by Brian M Culley , a net purchase of 25,500 shares made by Jill Ann Howe , and a net purchase of 6,730,770 shares made by Broadwood Partners Lp .

In summary, during the past 3 months, insiders sold 0 shares of Lineage Cell Therapeutics Inc (LCTX) in total and bought 110,000 shares, with a net purchase of 110,000 shares. During the past 18 months, 0 shares of Lineage Cell Therapeutics Inc (LCTX) were sold and 6,967,425 shares were bought by its insiders, resulting in a net purchase of 6,967,425 shares.

Lineage Cell Therapeutics Inc (LCTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Lineage Cell Therapeutics Inc Insider Transactions

No Available Data

What does Asterias Biotherapeutics Inc do?

Who are the key executives at Asterias Biotherapeutics Inc?

Don M Bailey is the director of Asterias Biotherapeutics Inc. Other key executives at Asterias Biotherapeutics Inc include other: See Remarks Below Neal C Bradsher , other: See Remarks Below Broadwood Partners Lp , and other: See Remarks Below Broadwood Capital Inc .

Asterias Biotherapeutics Inc (AST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Asterias Biotherapeutics Inc (AST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Asterias Biotherapeutics Inc (AST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Asterias Biotherapeutics Inc (AST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Asterias Biotherapeutics Inc Insider Transactions

No Available Data

What does OncoCyte Corp do?

Who are the key executives at OncoCyte Corp?

Don M Bailey is the director of OncoCyte Corp. Other key executives at OncoCyte Corp include 10 percent owner Broadwood Partners Lp , Interim CEO Josh Riggs , and other: Former Director John Peter Gutfreund .

OncoCyte Corp (OCX) Insider Trades Summary

Over the past 18 months, Don M Bailey made no insider transaction in OncoCyte Corp (OCX). Other recent insider transactions involving OncoCyte Corp (OCX) include a net purchase of 3,735,339 shares made by Broadwood Partners Lp , a net purchase of 53,670 shares made by , and a net purchase of 33,898 shares made by Andrew Arno .

In summary, during the past 3 months, insiders sold 0 shares of OncoCyte Corp (OCX) in total and bought 1,369,009 shares, with a net purchase of 1,369,009 shares. During the past 18 months, 0 shares of OncoCyte Corp (OCX) were sold and 3,826,297 shares were bought by its insiders, resulting in a net purchase of 3,826,297 shares.

OncoCyte Corp (OCX)'s detailed insider trading history can be found in Insider Trading Tracker table.

OncoCyte Corp Insider Transactions

No Available Data

What does Mallinckrodt PLC do?

Who are the key executives at Mallinckrodt PLC?

Don M Bailey is the director of Mallinckrodt PLC. Other key executives at Mallinckrodt PLC include director & President and CEO Sigurdur O Olafsson , 10 percent owner Fyi S.a R.l. , and 10 percent owner Ffi Iii S.a R.l. .

Mallinckrodt PLC (MNKKQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Mallinckrodt PLC (MNKKQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Mallinckrodt PLC (MNKKQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Mallinckrodt PLC (MNKKQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mallinckrodt PLC Insider Transactions

No Available Data

What does Staar Surgical Co do?

Who are the key executives at Staar Surgical Co?

Don M Bailey is the director of Staar Surgical Co. Other key executives at Staar Surgical Co include 10 percent owner Broadwood Partners Lp , Chief Operating Officer Warren Foust , and Chief Clinical & Regulatory, Magda Michna .

Staar Surgical Co (STAA) Insider Trades Summary

Over the past 18 months, Don M Bailey made no insider transaction in Staar Surgical Co (STAA). Other recent insider transactions involving Staar Surgical Co (STAA) include a net purchase of 2,065,549 shares made by Broadwood Partners Lp , a net purchase of 3,750 shares made by Aimee S Weisner , and a net purchase of 2,500 shares made by Elizabeth Yeu Lin .

In summary, during the past 3 months, insiders sold 0 shares of Staar Surgical Co (STAA) in total and bought 80,200 shares, with a net purchase of 80,200 shares. During the past 18 months, 0 shares of Staar Surgical Co (STAA) were sold and 2,073,964 shares were bought by its insiders, resulting in a net purchase of 2,073,964 shares.

Staar Surgical Co (STAA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Staar Surgical Co Insider Transactions

No Available Data

What does Comarco Inc do?

Who are the key executives at Comarco Inc?

Don M Bailey is the director of Comarco Inc. Other key executives at Comarco Inc include 10 percent owner Neal C Bradsher , 10 percent owner Broadwood Partners Lp , and 10 percent owner Broadwood Capital Inc .

Comarco Inc (CMRO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Comarco Inc (CMRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Comarco Inc (CMRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Comarco Inc (CMRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Comarco Inc Insider Transactions

No Available Data

What does Mallinckrodt PLC do?

Who are the key executives at Mallinckrodt PLC?

Don M Bailey is the director of Mallinckrodt PLC. Other key executives at Mallinckrodt PLC include 10 percent owner Alta Fundamental Advisers Llc , EVP & Head of Corp Development Jason Daniel Goodson , and EVP & Head of Spec Generics Stephen Andrew Welch .

Mallinckrodt PLC (MCKPF) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Mallinckrodt PLC (MCKPF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Mallinckrodt PLC (MCKPF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Mallinckrodt PLC (MCKPF)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mallinckrodt PLC Insider Transactions

No Available Data

Don M Bailey Mailing Address

Above is the net worth, insider trading, and ownership report for Don M Bailey. You might contact Don M Bailey via mailing address: 1300 N. Kellogg Drive, Suite D, Anaheim Ca 92607.

Discussions on Don M Bailey

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.